Mar 03, 2015 9:31am EST Twelve Months Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to Be Presented at ENDO 2015 Conference
Feb 26, 2015 10:30am EST OPKO to Announce Fourth Quarter and Full Year 2014 Financial Results on February 27, 2015
Feb 20, 2015 12:37pm EST OPKO Announces Publication of 20 Year Outcome Study for Lethal Prostate Cancer Using Kallikrein Biomarkers in 4Kscore Test
Feb 13, 2015 12:13pm EST OPKO Health to Present at the 2015 RBC Capital Markets’ Healthcare Conference
Jan 30, 2015 11:58am EST OPKO Submits Investigational New Drug Application to Initiate a Phase 2a Trial for its Long-Acting Coagulation Factor VIIa-CTP to Treat Hemophilia
Jan 13, 2015 11:49am EST OPKO Claros1 Analyzer Selected for Development of a Rapid Lyme Disease Test Under Immuno Technologies NIH Grant